Jan 22 2024

Florida Governor Says Marijuana Legalization Initiative Will be on This November’s Ballot

Florida Governor Ron DeSantis in recent remarks said that a marijuana legalization initiative will be on this November’s ballot, giving indication that he believes an effort by the state’s attorney general to block the vote will be rejected by the Florida Supreme Court.

Last year the Florida Division of Elections confirmed that the Smart & Safe Florida campaign submitted 967,528 validated signatures on their initiative to legalize recreational marijuana, more than the 891,523 signatures required to put the measure a on the November, 2024 general election ballot.

In November the Florida Supreme Court heard arguments on whether or not the initiative should be put to a vote in November, with the hearing spurred by a challenge from Attorney General Ashley Moody. The court has not yet ruled on the case, with an April 1 deadline fast approaching.
Continue reading

Jan 22 2024

Nevada Made $10 Million in Taxes From $68 Million in Marijuana Sales in October

Licensed marijuana stores sold nearly $70 million worth of marijuana in October, garnering the state nearly $10 million in tax revenue.

Legal marijuana sales were $67,921,099 in October throughout Nevada, according to the Nevada Department of Taxation. This resulted in the state bringing in $9,978,856 in marijuana tax revenue.

Total tax revenue for the fiscal year-to-date (starting July 1) is $40,473,664. This was made from the legal distribution of $277,602,500 worth of marijuana and marijuana products.
Continue reading

Jan 22 2024

Massachusetts: Record-Breaking $158.7 Million in Marijuana Sold in December, $1.8 Billion For 2023

There was more legal marijuana sold in December in Massachusetts than any month prior.

There was $158.7 million worth of marijuana sold legally in December, narrowly breaking the previous monthly record of $158.3 million sold in August.

According to data compiled and released by the Massachusetts Cannabis Control Commission, $140.1 million of the marijuana sold in December was recreational marijuana, while medical marijuana sales reached $18.6 million.
Continue reading

Jan 22 2024

Missouri: $123 Million in Legal Marijuana Sold in December, $1.3 Billion for 2023

December marijuana sales fell just short of the monthly record set earlier this year.

December marked the 10th straight month that legal marijuana sales surpassed $100 million in Missouri. In total there was $123.3 million worth of marijuana sold, coming within $3 million of the record-setting $126 million sold in March. $106.5 million of the marijuana sold in December was purchased by recreational consumers, while $16.8 million was purchased by medical marijuana patients.

Sales for all of 2023 reached $1.3 billion, resulting in over $100 million in tax revenue for the state. All-time sales for legal marijuana is now just shy of $2 billion.
Continue reading

Jan 19 2024

National Poll Shows President Biden’s Favorability Rating Will Jump 11% Among Likely Voters if Marijuana is Rescheduled

A new nationwide poll finds that a strong majority of American voters support rescheduling marijuana, and if the government does so this year it will give President Biden a large favorability jump.

Conducted by Lake Research Partners, the poll found that 58% of likely voters support rescheduling marijuana, moving it from its current Schedule I status to Schedule III. Just 19% oppose this move, which would legalize medical marijuana for prescription use nationwide while providing medical marijuana patients and businesses with a plethora of legal protections.

Rescheduling marijuana was supported by a majority of all age groups and political affiliations, but was unsurprisingly highest among those aged 18 to 25 with 65% in support and just 14% opposed.
Continue reading

Jan 19 2024

California Committee Unanimously Approves Psychedlics Bill

Two committees in the California Assembly have given approval to a bill to establish a psychedelics work group to prepare the state for legalization.

Psilocybin (“magic”) mushrooms.

The Assembly Appropriations Committee voted 11 to 0 today to pass Assembly Bill 941, filed by Assemblymember Mari Waldron (R). The committee’s vote comes nine days after it was approved, also unanimously, through the Assembly Health Committee, and a little over three months after Governor Gavin Newsom vetoed a bill that would have legalized certain psychedelics including psilocybin, DMT and ibogaine.

This bill “would require the California Health and Human Services Agency to convene a workgroup to study and make recommendations on the establishment of a framework governing psychedelic-assisted therapy, as defined.”
Continue reading

Jan 18 2024

Hawaii Bill to Decriminalize Marijuana Passed Through First Reading in House of Representatives

Legislation to decriminalize the possession of up to an ounce of marijuana has been passed through its initial reading in the Hawaii House of Representatives.

House Bill 1596 was filed Wednesday by State Representative David Tarnas along with a coalition of 11 other lawmakers. Yesterday the measure “passed First Reading”, with it needing to be passed through two additional readings before it can be sent to the Hawaii Senate.

In 2019 lawmakers in Hawaii passed a limited marijuana decriminalization law that removed criminal penalties for possessing up to three grams of marijuana, making it at most an $125 ticket. House Bill 1596 would increase the three gram limit to be 28 grams (one ounce), and it would reduce the ticket to just $25.
Continue reading

Jan 18 2024

Washington Senate Votes Unanimously to Allow the Sale of Cannabis Waste

Legislation that would allow licensed cannabis producers and processor “to sell specified solid waste generated during cannabis production or processing under certain conditions” has been passed by Washington’s full Senate.

Senate Bill 5376 was approved through the Senate yesterday in a unanimous 48 to 0 vote. The measure was filed by Senator Derek Stanford (D) and is cosponsored by Senators Anna Rivers (R), Karen Keiser (D), Rebecca Saldana (D) and Claire Wilson (D).

The measure states that “A licensed cannabis producer and a licensed cannabis processor may sell cannabis waste to a person not licensed by LCB if:
Continue reading

Jan 18 2024

Federal Bill to Deschedule Marijuana Likely the Prime Vehicle for Marijuana Reform if Democrats Take Back Congress

Legislation to fully deschedule marijuana while allowing expungements has 82 sponsors in the House of Representatives, but its chances in the Republican controlled chamber are slim to none – for now.

The Marijuana Opportunity Reinvestment and Expungement (MORE) Act was filed in September with five sponsors. In the four months since being filed, 77 additional lawmakers have signed on as cosponsors, bringing the total to 82. This represents nearly 20% of the entire 435-member House of Representatives. However, all of the measure’s cosponsors are Democrats, providing a slim outlook in the near future in a chamber that’s controlled by Republicans.

This outlook could change by the end of the year, given every member of the House is up for reelection this November, and polling shows that there’s a reasonable chance the Democrats could take back majority control of the House of Representatives. If they were to do so, the sheer number of Democrats sponsoring the MORE Act indicate that it could be the primary vehicle for reforming marijuana laws, something many Democrat leaders have vowed to fight for.
Continue reading

Jan 18 2024

American Nurses Association Applauds Department of Health’s Recommendation to Reschedule Marijuana

The American Nurses Association has issued a press release applauding the US Department of Health and Human Services’ (HHS) recommendation to the DEA that it move marijuana from Schedule I to Schedule III of the Controlled Substances Act.

The American Nurses Association (ANA), formed in 1896 and representing over five million registered nurses across the United States, calls the recommendation “a positive step toward developing an evidence-based approach for marijuana and related-cannabinoids use in disease and symptom management.”

ANA’s press release notes that “HHS’ Assistant Secretary for Health, Rachel L. Levine, M.D, recommended marijuana be reconsidered as a Schedule III drug given it poses lower health risks than other controlled substances and offers possible medical benefits. While the DEA has yet to act on this recommendation, the American Nurses Association (ANA) recognizes this as an accomplishment in realizing the potential for marijuana in health care delivery.”
Continue reading